Search
Returning search results with filters:
Remove filter for
Category: Health products
Remove filter for
Issue: Product safety
Remove filter for
Last updated: 2021
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2021
- December 20211 results available
- November 20214 results available
- October 20211 results available
- September 20211 results available
- August 20212 results available
- July 20212 results available
- June 20214 results available
- April 20212 results available
- March 20218 results available
- February 20212 results available
- January 20213 results available
Displaying 16 - 30 of 30 items.
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
AlertHealth professional risk communication | 2021-04-28
Importation of Janssen COVID-19 Vaccine with Two Types of English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-04-26
Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels (US-Labelled Supply)
AlertHealth professional risk communication | 2021-03-31
Recall of certain hand sanitizers that may pose health risks (Part 1 - June 17, 2020 to March 24, 2021)
AlertPublic advisory | 2021-03-24
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia
AlertHealth professional risk communication | 2021-03-24
Counterfeit respirators
AlertPublic advisory | 2021-03-19
Counterfeit 3M N95 respirators
AlertPublic advisory | 2021-03-19
Pfizer-BioNTech COVID-19 Vaccine: Updated Storage and Transportation Conditions
AlertHealth professional risk communication | 2021-03-08
Authorization of Janssen COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-08
Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-01
COVID-19 Vaccine Moderna: Updated English-only Global Vial and Carton Labels and Post-Market Adverse Reaction Information
AlertHealth professional risk communication | 2021-02-22
Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market Adverse Reaction Information
AlertHealth professional risk communication | 2021-02-09
GILENYA (fingolimod) - Risk of Liver Injury
AlertHealth professional risk communication | 2021-01-18
Important Safety Information on SUBOXONE (buprenorphine and naloxone) and the Risk of Overdose or Underdose when Switching Between Dosage Forms or Routes of Administration
AlertHealth professional risk communication | 2021-01-07
Importation of German-labelled Hydromorphon Ethypharm Kalceks (Hydromorphone Hydrochloride Solution for Injection) due to Potential Shortage of Canadian-labelled HYDROmorphone
AlertHealth professional risk communication | 2021-01-06